• Press Release - New Funding Round
    Glysure Secures £7 Million in Series C Financing Round
  • Clinical Trials
    GlySure presents the latest human clinical trials.
  • Start-Up Profile The Gray Sheet
    Glysure featured in The Gray Sheet
  • Start-Up Magazine Interview
     Glysure CEO Chris Jones interviewed by Start-Up magazine
  • OneMedPlace - Breakthrough Article
    GlySure's Technology May Break Barrier for Tight Control & Automated Glucose Monitoring.

 


GlySure has developed a continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of Tight Glycemic Control and Intensive Insulin Therapy.
   

            

 

 

 

 

Infrequent glucose monitoring could be putting patient lives at risk. At present, clinicians do not have an easy, accurate and affordable technology to allow the frequent glucose monitoring required for Tight Glycemic Control (TGC) protocols.GlySure’s new technology exceeds the requirements of clinicians while also significantly reducing time and cost.

 

 
Contact Details
t: +44(0)1235 462 870
e: info@glysure.com
GlySure Limited Units 4-6 The Quadrant Abingdon Science Park Abingdon OX14 3YS | © GlySure Limited | All rights reserved. | Website design: DSD Marketing